Genscript Biotech Corp
HKEX:1548

Watchlist Manager
Genscript Biotech Corp Logo
Genscript Biotech Corp
HKEX:1548
Watchlist
Price: 10.82 HKD -0.92% Market Closed
Market Cap: 23B HKD
Have any thoughts about
Genscript Biotech Corp?
Write Note

Genscript Biotech Corp
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genscript Biotech Corp
Cash & Cash Equivalents Peer Comparison

Comparables:
603259
300759
2269
300347
W
2268

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Genscript Biotech Corp
HKEX:1548
Cash & Cash Equivalents
$1.4B
CAGR 3-Years
15%
CAGR 5-Years
39%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Cash & Cash Equivalents
ÂĄ14.7B
CAGR 3-Years
14%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Cash & Cash Equivalents
ÂĄ2.3B
CAGR 3-Years
-27%
CAGR 5-Years
46%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Cash & Cash Equivalents
ÂĄ9.2B
CAGR 3-Years
-7%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Cash & Cash Equivalents
ÂĄ3.2B
CAGR 3-Years
-30%
CAGR 5-Years
7%
CAGR 10-Years
23%
W
WuXi XDC Cayman Inc
HKEX:2268
Cash & Cash Equivalents
ÂĄ4B
CAGR 3-Years
422%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Genscript Biotech Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.4B USD

Based on the financial report for Jun 30, 2024, Genscript Biotech Corp's Cash & Cash Equivalents amounts to 1.4B USD.

What is Genscript Biotech Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
39%

Over the last year, the Cash & Cash Equivalents growth was 4%. The average annual Cash & Cash Equivalents growth rates for Genscript Biotech Corp have been 15% over the past three years , 39% over the past five years .

Back to Top